Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma

This study is looking at whether a single dose of intravenous (IV) Iron-Dextran Complex Injection (InFed) can help patients with acute blood loss anemia (low red blood cell count due to blood loss) after having surgery for a broken bone in their leg or pelvis. Anemia can cause problems like fatigue and increase risks after surgery. You might be able to join if you are 18-89 years old, have a lower extremity or pelvis fracture requiring surgery, and have acute blood loss anemia (hemoglobin between 7.0-11.0g/dL) within seven days after your surgery. The study will compare InFed to a saline placebo (a salt water solution with no medicine). Researchers will measure how many people enroll, how well the study plan is followed, and your fatigue levels after 3 months. The current status of this study is unclear.

Study design
This interventional study plans to enroll 150 participants. Participants will receive either a single 1000mg dose of Iron-Dextran Complex Injection (InFed) or a saline placebo.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months to assess enrollment rates, protocol adherence, and fatigue scores.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05292001

Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma

Recruiting
PHASE4Ages 18–89InterventionalTreatment
Oregon Health and Science University
~150 participants
Updated 2025-08-08 on ClinicalTrials.gov
What's tested:Iron-Dextran Complex Injection [InFed]Saline Placebo

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rate of participant enrollment and screen failures
Measured over 3 months
+2 more outcomes measured
Acute Blood Loss Anemia
Fracture
1 sites across 1 states
Oregon1
  • Zachary M Working, MD · PRINCIPAL_INVESTIGATOR · Oregon Health and Science University

Opens a ready-to-send draft in your own email app — review before sending.

  • Rate of participant enrollment and screen failures3 months

    Appraisal of feasibility based on rate of participant enrollment per year and rate of screening failures.

  • Evaluation of protocol adherence3 months

    Appraisal of feasibility based on proportion of participants completing each follow up visit and proportion of missing data.

  • Patient Reported Outcome Scores: Fatigue3 months

    PROMIS bank v1.0 - fatigue. Computer adaptive test that measures feelings of tiredness likely to decrease one's ability to execute daily activities and function normally in family or social roles. Scored on the T-score metric (average score 50, standard deviation 10). High scores mean more of the concept being measured.